Portfolio of Genomics Stocks
Genomics includes agrigenomics, bacterial genomics, bioinformatics, cancer genomics, diagnostics, drug discovery, equipment, pharmacogenomics and research.
Here is a table of 10 genomics stocks.
| 10 Genomics Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| Agilent Technologies | A | |
| Alnylam Pharmaceuticals | ALNY | |
| CRISPR Therapeutics | CRSP | |
| Editas Medicine | EDIT | |
| Exact Sciences | EXAS | |
| Illumina | ILMN | |
| Ionis Pharmaceuticals | IONS | |
| Myriad Genetics | MYGN | |
| QIAGEN N.V. | QGEN | |
| Sangamo Therapeutics | SGMO | |
| Sparkline weekly price charts based on Alpha Vantage data. | ||
| 10 Genomics Stocks | ||
|---|---|---|
Name | Symbol | Last Close |
| Agilent Technologies | A | $126.38 |
| Alnylam Pharmaceuticals | ALNY | $196.79 |
| CRISPR Therapeutics | CRSP | $63.10 |
| Editas Medicine | EDIT | $12.33 |
| Exact Sciences | EXAS | $33.30 |
| Illumina | ILMN | $187.24 |
| Ionis Pharmaceuticals | IONS | $44.99 |
| Myriad Genetics | MYGN | $19.58 |
| QIAGEN N.V. | QGEN | $42.01 |
| Sangamo Therapeutics | SGMO | $4.78 |
Portfolio Values
To inspect the performance of the Genomics Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.All 10 stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,000.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.The current value of the $10,000 investment is $11,815. The percent return is 18.15%. The annualized return is 3.39%.
| 10 Genomics Stocks Returns | ||
|---|---|---|
Name | Symbol | Monthly Returns & Details |
| Agilent Technologies | A | 93.01% |
| Alnylam Pharmaceuticals | ALNY | 61.52% |
| CRISPR Therapeutics | CRSP | 226.94% |
| Editas Medicine | EDIT | -50.28% |
| Exact Sciences | EXAS | -39.44% |
| Illumina | ILMN | -8.75% |
| Ionis Pharmaceuticals | IONS | -21.22% |
| Myriad Genetics | MYGN | -42.88% |
| QIAGEN N.V. | QGEN | 24.07% |
| Sangamo Therapeutics | SGMO | -61.45% |
Portfolio Value Chart for Last 100 Daily Closes
Related Portfolios
Portfolio of Gene Editing (CRISPR) Stocks
Portfolio of Genetic Testing Stocks
Portfolio of Stem Cell Stocks